Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
273 result(s)
Pollen season is highly heterogenous in Southern European countries
01-03-2020
European Academy of Allergy and Clinical Immunology criteria for pollen season may include many intermittent days with low pollen concentrations.
Nasal nitric oxide in children with asthma and allergic rhinitis
01-03-2020
The study compares nasal nitric oxide levels in upper airways in children with respiratory diseases.
Ellipta inhaler
27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.
Sitemap
GlaxoSmithKline (GSK) UK healthcare professional website site map.
GSK support for healthcare professionals in response to COVID-19
Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.
DECTOVA▼
Zanamivir IV</br> Influenza
Requip & Adartrel (Ropinirole) artwork change | GSKpro
Information for changes to the colour of the ink on both the cartons and blister packs of Requip and a blister pack of Adartrel.
Supply
Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability
Falsified Medicines Directive
Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.
Homepage
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Therapy areas
GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.
COPD Exacerbations
COPD treatment information to support UK healthcare professionals
COPD expert perspectives
Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.
COPD triple therapy
COPD treatment information to support UK healthcare professionals
Medicines management and optimisation
Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects
Respiratory
Overview of Asthma and COPD
Asthma
Overview of Asthma
Severe Asthma
Overview of severe asthma
Ellipta critical error studies in asthma
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their asthma patients
Ellipta critical error studies in COPD
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients
Oncology Expert Insights
Expert opinion on ovarian cancer treatment to support UK healthcare professionals
Vaccines
GSK UK information about our vaccines and disease awareness campaigns
Ordering and delivery
Find out how to set up an account and start ordering GSK vaccines.
Contact us
GSK UK contact page for healthcare professionals
Request a contact
Contact us form for UK healthcare professionals to contact GSK
Report Adverse Event
Form for UK healthcare professionals to report an adverse event related to a GSK product
Educational Resources
Educational resources for health professionals about Allergic Rhinitis
device
Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video
device
Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video
guidelines
Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children
Avamys Overview
Avamys topic index: request, indications, patients, device, efficacy, action, guidelines
safety
Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate
management-of-AR
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
videos
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
efficacy
Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video
indication
Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient
Avamys (fluticasone furoate) - Guidelines
Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children
Avamys (fluticasone furoate) Overview
Avamys (fluticasone furoate) topic index: request, indications, patients, device, efficacy, action, guidelines
Avamys (fluticasone furoate) - safety
Avamys (fluticasone furoate) - safety information in adults and children
management-of-AR
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
Avamys (fluticasone furoate) - videos
Avamys videos: differential diagnosis and management
efficacy
Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video
Avamys (fluticasone furoate) - indication
Avamys (fluticasone furoate) is indicated for the treatment of the symptoms of allergic rhinitis in adults, adolescents and children (6 years and over).
device
Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video
guidelines
Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children
Avamys Overview
Avamys topic index: request, indications, patients, device, efficacy, action, guidelines
safety
Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate
management-of-AR
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
videos
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
efficacy
Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video
indication
Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient
Products
GSK product information for UK healthcare professionals
Varilrix
Varilrix – Chickenpox/varicella vaccine product information to support UK healthcare professionals
Mode of action
Bexsero Meningitis B vaccine mode of action information for UK healthcare professionals
Invasive Meningococcal Disease
Bexsero Meningitis B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD)
Epidemiology
Bexsero Men B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD) epidemiology
Transmission and symptoms
Bexsero Meningitis B vaccine transmission and symptoms information for UK healthcare professionals
Bexsero
Bexsero Meningitis B vaccine information for UK healthcare professionals
Bexsero Overview
Bexsero Meningitis B vaccine overview for UK healthcare professionals
Seretide inhaler technique and safety
Videos and materials to help you ensure your patients are using their Seretide Accuhaler and Evohaler correctly.
Adartrel
Adartrel (ropinirole hydrochloride) - links to the summary of product characteristics, patient information leaflet and supply information to support UK healthcare professionals.
Duac (clindamycin / benzoyl peroxide) Prescribing Information | GSKpro
An overview of Duac formulation, strengths, indication and how to prescribe.
Duac (clindamycin / benzoyl peroxide) - Resources | GSKpro
Duac materials (leaflets) to support UK healthcare professionals
Duac (clindamycin / benzoyl peroxide) - EDF guideline | GSKpro
An overview of the EDF guideline recommendations for the treatment.
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) vs Monotherapy | GSKpro
Duac with monotherapies comparison.
Duac (clindamycin / benzoyl peroxide) - Why Duac? | GSKpro
Why to choose Duac supporting information.
Duac (clindamycin / benzoyl peroxide) vs Zineryt | GSKpro
Duac with erythromycin/zinc (Zineryt) comparison.
Duac (clindamycin / benzoyl peroxide) mode of action | GSKpro
Duac information about mode of action and antibiotic resistance
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac information to support UK healthcare professionals
Duac (clindamycin / benzoyl peroxide) - Heritage & Efficacy | GSKpro
An overview of GSK Heritage. Duac helping patients for over 15 years.
Duac (clindamycin / benzoyl peroxide) - mode of action video | GSKpro
Video about Duac mode of action
Duac (clindamycin / benzoyl peroxide) - complications video | GSKpro
Video about meeting the challenges of complications.
Duac (clindamycin / benzoyl peroxide) - a scientific update | GSKpro
Video about a scientific update.
Duac (clindamycin / benzoyl peroxide) Videos | GSKpro
Duac Videos to support UK healthcare professionals.
Duac (clindamycin phosphate/benzoyl peroxide) - infographics for healthcare professionals
Duac - information for healthcare professionals on the treatment (infographics)
Duac (clindamycin / benzoyl peroxide) - e-modules | GSKpro
E-modules to support UK healthcare professionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Trelegy▼ Ellipta
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) product information & resources to support UK healthcare professionals in their daily practice.
Efficacy and safety
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) efficacy and safety information to support UK healthcare professionals.
Quality of Life (IMPACT)
Health-related QoL efficacy results for TRELEGY Ellipta
Efficacy
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Lung Function (IMPACT)
Lung Function efficacy results for TRELEGY Ellipta
Exacerbations (IMPACT)
Exacerbation efficacy results for TRELEGY Ellipta.
Video Testimonials: I've Seen Meningitis
Video testimonials from healthcare professionals about the impact of meningitis
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
